Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.17B 3.73B 475M 425M 393M 355M 664M 45.23B 675M 4.68B 1.87B 23.67B 1.78B 1.74B 74.98B P/E 2026 *
6.96x
P/E 2027 * 6.18x
Enterprise Value 3.17B 3.73B 475M 425M 393M 355M 664M 45.23B 675M 4.68B 1.87B 23.67B 1.78B 1.74B 74.98B EV / Sales 2026 *
0.45x
EV / Sales 2027 * 0.42x
Free-Float
45.7%
Yield 2026 *
6.47%
Yield 2027 * 7.28%
08-28 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
08-28 Tong Ren Tang Technologies Co. Ltd. Enters New E-Commerce Service Cooperation Framework Agreement with Beijing Tong Ren Tang Shuzi Technology Co., Ltd CI
07-09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-27 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
1 day-0.85%
1 week-3.96%
Current month-6.73%
1 month-7.03%
3 months-18.49%
6 months-24.42%
Current year-34.01%
1 week 2.88
Extreme 2.88
3.06
1 month 2.88
Extreme 2.88
3.2
Current year 2.88
Extreme 2.88
4.56
1 year 2.88
Extreme 2.88
4.95
3 years 2.88
Extreme 2.88
7.03
5 years 2.88
Extreme 2.88
9.28
10 years 2.88
Extreme 2.88
15.42
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 37 09/07/2026
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-0.85%-3.96%-37.15%-51.50% 479M
+6.63%+5.13%+68.86%+145.20% 1,148B
+1.53%+2.84%+47.48%+89.01% 652B
+1.68%+1.96%+29.16%+109.31% 505B
+0.73%+2.45%+54.26%+68.96% 384B
+3.83%-0.62%+69.01%+42.32% 348B
+2.38%+2.65%+34.31%+57.95% 294B
+2.26%+0.55%+3.92%+28.92% 264B
+1.97%+3.01%+57.91%+76.14% 244B
+4.03%+5.36%+39.76%+116.14% 197B
Average +2.02%+1.72%+36.75%+68.25% 403.76B
Weighted average by Cap. +2.25%+2.89%+50.21%+95.95%

Financials

2026 *2027 *
Net sales 6.98B 8.22B 1.05B 938M 866M 783M 1.46B 99.77B 1.49B 10.33B 4.12B 52.21B 3.93B 3.85B 165B 7.56B 8.9B 1.13B 1.02B 938M 849M 1.59B 108B 1.61B 11.19B 4.46B 56.56B 4.26B 4.17B 179B
Net income 454M 535M 68.2M 61.09M 56.35M 51M 95.36M 6.49B 96.9M 672M 268M 3.4B 256M 250M 10.76B 514M 605M 77.05M 69.01M 63.67M 57.62M 108M 7.34B 109M 760M 303M 3.84B 289M 283M 12.16B
Net Debt - -
Projected Income Statement - Annual - Tong Ren Tang Technologies Co. Ltd.
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,801
Date Price Change Volume
29/10/26 HK$2.910 -0.85% 420,000
28/10/26 HK$2.935 -1.51% 1,237,000
27/10/26 HK$2.980 -2.30% 977,886
26/10/26 HK$3.050 +2.35% 2,349,000
23/10/26 HK$2.980 -1.65% 2,176,000
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Tong Ren Tang Technologies Co. Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.472CNY
Average target price
4.601CNY
Spread / Average Target
+86.15%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Tong Ren Tang Technologies Co. Ltd.
  1. Stock Market
  2. Stocks
  3. 1666 Stock